期刊文献+

灯盏生脉胶囊联合盐酸多奈哌齐片治疗轻至中度血管性痴呆的效果 被引量:16

下载PDF
导出
摘要 目的 观察灯盏生脉胶囊联合盐酸多奈哌齐片治疗轻、中度血管性痴呆(VD)的疗效及安全性。方法 采用简易精神状态检查表(MMSE)为主要评价指标,临床痴呆程度量表(CDR)、日常生活能力量表(ADL)及颈动脉内膜厚度为次要评价指标。将120例轻、中度VD患者(MMSE评分11~24分)随机分为两组。观察组服用灯盏生脉胶囊联合盐酸多奈哌齐片,对照组单独服用盐酸多奈哌齐片。结果 观察组较对照组MMSE评分明显改善(P〈0.01),CDR评分改善较为明显(P〈0.05),ADL评分改善不明显(P〉0.05)。结论 灯盏生脉胶囊联合盐酸多奈哌齐片治疗可显著改善轻、中度VD患者的认知功能、痴呆程度及防止病灶粥样硬化斑块发生发展,且安全性良好,是联合治疗VD的有效药物之一。
出处 《广东医学》 CAS CSCD 北大核心 2014年第16期2608-2610,共3页 Guangdong Medical Journal
  • 相关文献

参考文献17

  • 1贾建平,魏翠柏,方伯言.痴呆诊断中的几个问题[J].中华神经科杂志,2005,38(8):473-475. 被引量:13
  • 2何育生,王星,陈辉新,陆振康.脑梗死后痴呆的临床分析[J].中风与神经疾病杂志,2001,18(4):226-228. 被引量:22
  • 3RASQUIN S, LODDER J, VERHEY F. The association between psychiatric and cognitive symptons after stroke. A prospective study [J]. Cerebrovasc Dis, 2005, 19(5) : 309 -316.
  • 4American Psychiatric Association. Diagnostic and statistical nlau- hal of mental disorder[ M]. 4th ed. Washington DC: American Psychiatric Association, 1994: 1.
  • 5HAEHINSKI V C, ILIF L D, ZILHKA E, et al. Cerebral blood flow in demen-tia[J]. Arch Neurol, 1975, 32(9) : 632 -637.
  • 6FOLSTEIN M F, FOLSTEIN S E, MEHUGH P R. Mini - mental state : A practical method for grading the cognitive state subjects for the clinician [ J ]. J Psyehiatr Res, 1975, 12 (3) : 189 - 198.
  • 7汤德生,许示凯.促进学习记忆药物药理研究进展[J].老年医学杂志,2005,11(4):57-63.
  • 8MELIS F, STANEAMPIANO R, IMPERATO A, et al. Chronic ethanol consumption in tats: corralation between memory perform- ante and hippleampal acetylcholine release in vivo [ J ]. Neuro- science, 1996, 74( 1 ) : 155 - 159.
  • 9ROMAN G C, WILKINSON D G, DOODY R S, et al. Donepeil in vascular dementia: combined analysis of two large - scale clinical trials[J]. Dement Geriatr Cogn Disord, 2005, 20(6) : 338 -344.
  • 10张卫东,孔德云,李惠庭,顾正兵,秦路平.灯盏花的化学成分研究(Ⅰ)[J].中国医药工业杂志,1998,29(11):498-500. 被引量:60

二级参考文献54

  • 1贾建平.要重视卒中后痴呆的研究[J].中华医学杂志,2004,84(23):1941-1943. 被引量:6
  • 2贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:265
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 4陈清棠.脑卒中患者临床神经功能缺损程度评分标准[J].中国实用内科杂志,1997,17:313-313.
  • 5Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon 4 allele, elevated midlffe total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzhekner disease. Ann Intern Med, 2002. 137:149 - 155.
  • 6Meyer JS, Rauch G, Rauch RA, et al. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Nenrobiol Aging, 2000, 21 : 161 - 169.
  • 7Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet, 1996, 347:1141 - 1145.
  • 8Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brah weight at death: the HAAS. Honokdu-Asia aging Study. Neurobiol Aging, 2000, 21:57 -62.
  • 9de la Torre JC. Cerebral hypoperfusion, capiliary degeneration, and development of Alzhehner disease. Alzheimer Dis Assoc Disord, 2000,14(Suppl 1): S72 -S81.
  • 10Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology, 1998, 51:986 -993.

共引文献183

同被引文献238

引证文献16

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部